Cancer Prevention & Research Institute of Texas

Cancer Prevention & Research Institute of Texas

Cancer Prevention & Research Institute of Texas

Overview
Date Founded

2007

Headquarters

1701 North Congress Avenue,Suite 6-127,Austin, TX 78701

Employees (Worldwide)

1 - 10

Industries

Biotechnology
Market & Policy Research
Holding Companies
IT Consulting & Services
Medical Support Services
Hospitals & Patient Services

Company Description

Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX.

Contact Data
Trying to get in touch with decision makers at Cancer Prevention & Research Institute of Texas? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Operating Officer

General Counsel & Deputy Executive Officer

Chief Scientific Officer

Chief Prevention Officer

Chief Product Development Officer

Vice Chairman

Attorney

Grant Compliance Specialist

Counselor

Paths to Cancer Prevention & Research Institute of Texas
Potential Connections via
Relationship Science
You
Cancer Prevention & Research Institute of Texas
Advisors & Consultants
Advisor

Deputy Assistant Secretary, Health-Women's Health at United States Department of Health & Human Services

Clients

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
$7.5M
05/2015
Suppliers
Bellicum Pharmaceuticals Inc. Hospitals & Patient Services | Houston, TX

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.

Aravive, Inc. Biotechnology | Houston, TX

Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cancer Prevention & Research Institute of Texas. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cancer Prevention & Research Institute of Texas's profile does not indicate a business or promotional relationship of any kind between RelSci and Cancer Prevention & Research Institute of Texas.